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Abstract	
Macrophages	are	found	throughout	the	body,	where	they	play	crucial	roles	in	tissue	
development,	homeostasis	and	remodelling,	as	well	as	being	sentinels	of	the	innate	immune	
system	that	can	contribute	to	protective	immunity	and	inflammation.	Barrier	tissues	such	as	
the	 intestine,	 lung,	 skin	 and	 liver	 are	 exposed	 constantly	 to	 the	 outside	 world,	 placing	
special	 demands	 on	 resident	 cell	 populations	 such	 as	 macrophages.	 Here	 we	 review	 the	
mounting	evidence	that	although	macrophages	 in	different	barrier	 tissues	may	be	derived	
from	 distinct	 progenitors,	 their	 highly	 specific	 properties	 are	 shaped	 by	 the	 local	
environment,	allowing	them	to	adapt	precisely	to	the	needs	of	their	anatomical	niche.	We	
discuss	 the	 properties	 of	macrophages	 in	 steady	 state	 barrier	 tissues,	 outline	 the	 factors	
that	 shape	 their	 differentiation	 and	 behaviour	 and	 describe	 how	 macrophages	 change	
during	protective	immunity	and	inflammation.	
	
Introduction	
Macrophages	are	one	of	the	most	abundant	populations	of	leukocytes	in	the	body.	
They	play	important	roles	in	innate	immunity	and	inflammation1,	but	are	also	crucial	for	the	
development	 and	 homeostatic	maintenance	 of	 normal	 tissues,	 as	well	 as	 in	 the	 repair	 of	
damaged	 tissue2.	Hence,	 there	 is	 considerable	 interest	 in	exploring	how	macrophages	are	
tailored	 to	 the	 physiological	 demands	 of	 their	 environment	 and	 how	 this	 changes	 when	
homeostasis	is	perturbed.		
	 Until	 very	 recently,	 it	was	believed	 that	macrophage	behaviour	could	be	explained	
by	dividing	them	into	discrete	subsets	 (“M1-like”	and	“M2-like”)	based	on	their	 functional	
properties.	 However	 work	 over	 the	 past	 few	 years	 shows	 that	 this	 approach	 is	 over-
simplistic3	 and	 that	 macrophages	 are	 highly	 heterogeneous,	 possessing	 specialised	
properties	 that	 are	 precisely	 adapted	 to	 individual	 tissues.	 In	 parallel	 it	 is	 now	 clear	 that	
local	factors	in	the	environment	control	how	macrophages	develop	and	function	under	both	
steady	state	and	inflammatory	conditions.	Here	we	discuss	how	this	new	understanding	of	
macrophage	 biology	 provides	 insights	 into	 the	 behaviour	 of	 these	 cells	 in	 the	 most	
immunologically	active	tissues	 in	 the	body,	 the	barrier	surfaces	of	 the	skin,	 intestine,	 lung	
and	 liver.	As	these	sites	are	exposed	continuously	 to	the	external	environment	and	are	of	
crucial	physiological	 importance,	they	require	constant	monitoring	for	pathogens,	but	also	
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maintenance	of	tissue	integrity.	As	a	result,	immune	cells	in	the	barrier	surfaces	are	subject	
to	unique	demands	and	the	macrophage	populations	have	developed	many	properties	that	
are	 specifically	 adapted	 to	 each	 tissue.	 After	 discussing	 the	 processes	 that	 regulate	
macrophage	 function	 under	 steady	 state	 conditions,	 we	 will	 then	 describe	 how	 these	
populations	in	response	to	local	inflammation.	
		
Macrophages	in	Steady	State	Tissues	
Macrophages	are	 sessile	mononuclear	cells	 found	 in	all	 tissues	of	 the	body,	where	
they	 have	 the	 appearance	 of	 large	 vacuolated	 cells	 with	 abundant	 cytoplasm	 containing	
lysosomal	granules.	Classically,	tissue	macrophages	have	been	identified	by	their	expression	
of	 the	 phenotypic	 markers	 F4/80	 and	 CD68	 in	 mice	 and	 humans	 respectively.	 However	
recent	multi-parameter	flow	cytometric	analyses	and	genome-wide	transcriptional	profiling	
have	 revealed	 additional	 generic	 markers	 that	 identify	 macrophages	 across	 a	 range	 of	
tissues4	 (Table	 1).	 Of	 particular	 note	 and	 of	 practical	 importance,	 expression	 of	 the	 high	
affinity	 IgG	receptor	CD64	and	the	Mer	tyrosine	kinase	(MerTK)	associated	with	uptake	of	
apoptotic	 cells	 is	 common	 to	most	 tissue	macrophages	 in	mice;	 these	 are	 not	 expressed	
highly	by	other	mononuclear	phagocytes,	such	as	dendritic	cells	5.		
Layered	 on	 top	 of	 this	 common	 signature,	 macrophages	 in	 individual	 tissues	 are	
remarkably	 heterogeneous	 in	 terms	 of	 their	 surface	 phenotype,	 transcriptome	 and	
epigenome	(Table	1	and	see	below).	Although	many	of	their	functions	are	conserved	across	
tissues,	including	key	housekeeping	functions	such	as	clearance	of	apoptotic	and	senescent	
cells,	 individual	 populations	 of	 macrophages	 are	 highly	 adapted	 to	 the	 needs	 of	 their	
environment,	 fulfilling	 roles	 specific	 to	 the	 particular	 tissue,	 and	 even	 subcompartments	
within	 tissues6.	 This	 heterogeneity	 is	 not	 surprising	 given	 the	 significant	 differences	
between	organs	in	terms	of	their	physiological	functions,	exposure	to	microbiota,	nutrients	
and	metabolites,	and	the	fact	that	macrophages	develop	synchronously	with	their	organ	of	
residence7.	 For	 a	 time,	 it	 was	 believed	 that	 these	 differences	 might	 reflect	 distinct	
developmental	 origins	 of	 macrophages,	 but	 it	 now	 seems	 more	 likely	 that	 local	
environmental	 imprinting	 is	 the	major	 determinant	 in	macrophage	 identity	 and	 function,	
irrespective	of	their	origin8.	As	the	wider	aspects	of	macrophage	development	have	recently	
been	reviewed	extensively	elsewhere	(eg	see	7-12),	here	we	restrict	our	discussion	of	those	
aspects	of	macrophage	origin	and	development	that	are	specific	to	the	barrier	surfaces.		
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Intestinal	macrophages.		
Macrophages	 are	 abundant	 in	 all	 layers	 of	 the	 normal	 small	 and	 large	 intestines,	
including	 the	 lamina	 propria	 of	 the	 mucosa,	 the	 muscularis	 externa	 and	 the	 serosa	 that	
separates	 the	 intestine	 from	the	peritoneal	 cavity.	The	 largest	population	 is	 in	 the	 lamina	
propria,	 where	 they	 are	 often	 found	 immediately	 below	 the	 single	 layer	 of	 columnar	
epithelium.	In	mice,	mature	macrophages	of	the	lamina	propria	express	high	levels	of	major	
histocompatibility	complex	type	II	(MHCII)	molecules,	and	most	express	CD11c	(integrin	ax)	
normally	found	on	dendritic	cells,	often	leading	to	confusion	between	the	two	cell	types	in	
the	 intestine13	 14-17	 (Table	 1).	 They	 are	 also	 rich	 in	 receptors	 associated	 with	 phagocytic	
activity	 and	 uptake	 of	 apoptotic	 cells,	 such	 as	 CD163,	 CD206,	 TIM4,	 avb5	 integrin	 and	
CD3614,18-21.	 Importantly,	human	intestinal	macrophages	share	many	of	these	features14,22	
(Table	1).	
	 Unlike	 many	 other	 tissue	 resident	 macrophages,	 those	 in	 the	 adult	 intestine	 are	
dependent	 on	 constant	 replenishment	 by	 bone	 marrow	 derived	 monocytes	 which	 then	
differentiate	 locally	 under	 the	 control	 of	 factors	 in	 the	 intestinal	 microenvironment	
including	TGFb	-	a	process	known	as	the	“monocyte	waterfall”20,23-25	(Figure	1A).	This	occurs	
continuously	 through	a	series	of	 intermediary	stages	and	allows	 flexible	adaptation	to	the	
mucosa,	a	highly	dynamic	 tissue	both	 in	 terms	of	 its	exposure	to	 the	various	challenges	 it	
faces	 from	 the	 outside	 world	 and	 the	 rapid	 turnover	 of	 the	 epithelium.	 During	 their	
differentiation,	mucosal	macrophages	progressively	acquire	their	characteristic	phenotype,	
together	 with	 a	 number	 of	 functions	 that	 contribute	 to	 homeostasis	 in	 the	 steady	 state	
intestine	 (Figure	 1A).	 They	 have	 avid	 phagocytic	 activity	 and	 are	 bactericidal	 without	
exogenous	 stimulation	 and	 together	 with	 their	 subepithelial	 location,	 they	 are	 ideally	
situated	 to	deal	with	pathogenic	microbes	 that	 invade	across	 the	 intestinal	epithelium,	as	
well	 as	 contribute	 to	 the	 symbiotic	 relationship	 with	 the	 microbiota19,25-27.	 Local	
macrophages	can	also	help	preserve	integrity	of	the	mucosa	in	a	number	of	ways.	First	their	
scavenger	 properties	 will	 enable	 them	 to	 deal	 with	 the	 large	 amount	 of	 cell	 death	 that	
occurs	 routinely	 in	 this	 highly	 dynamic	 tissue.	 Secondly	 they	 secrete	mediators	 that	 drive	
epithelial	 cell	 renewal,	 including	 hepatocyte	 growth	 factor	 (HGF)28,	members	 of	 the	Wnt	
signalling	 pathway29-31	 and	 PGE232.	 Finally	 they	 produce	 metalloproteinases	 that	 may	
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promote	 tissue	 remodelling20.	 As	 a	 result,	 loss	 of	mucosal	macrophages	 in	mice	 leads	 to	
dysregulated	 enterocyte	 differentiation	 and	 increased	 susceptibility	 to	 inflammatory	
damage(33,34	and	see	below).	
A	 prominent	 feature	 of	 steady	 state	 intestinal	 macrophages	 is	 their	 constitutive	
production	of	anti-inflammatory	cytokine	IL1014,21,35,36,	together	with	low	levels	of	the	pro-
inflammatory	mediators	 TNFa	 and	 IL1b14,37,38.	 Despite	 this	 evidence	 of	 activation	 in	 situ,	
intestinal	 macrophages	 are	 unresponsive	 to	 exogenous	 stimuli,	 failing	 to	 produce	 nitric	
oxide,	 reactive	 oxygen	 species	 (ROS)	 or	 pro-inflammatory	 cytokines	 when	 stimulated	 by	
agents	such	as	TLR	 ligands14. This	does	not	reflect	a	failure	to	express	appropriate	pattern	
recognition	 receptors	 (PRR),	 but	 rather	may	 be	 due	 to	 active	 inhibitory	mechanisms	 that	
block	the	relevant	signalling	pathways22,39,40.	Signalling	via	the	IL10	receptor	plays	a	crucial	
role	 in	 the	 functional	 “anergy”	 of	 intestinal	 macrophages,	 with	 defects	 in	 this	 pathway	
leading	to	macrophage	hyperactivity	and	inflammatory	bowel	disease21,41-43.	IL10	produced	
by	macrophage	 themselves	 is	 not	 essential	 for	 this	 process	 and	additional	 sources	of	 this	
cytokine	in	the	mucosa,	such	as	CD4+	T	cells,	seem	to	be	more	important21.		
Intestinal	 macrophages	 are	 also	 important	 sources	 of	 mediators	 that	 help	 maintain	
other	 immune	 cells	 in	 their	 vicinity.	Macrophage-derived	 IL10	 sustains	 the	 expansion	 and	
survival	of	 inducible	FoxP3+	Treg	 in	 the	LP35,44,	a	process	 that	 is	 important	 for	 tolerance	 to	
orally	 administered	 antigens44.	 In	 parallel,	 the	 numbers	 of	 endogenous	 FoxP3+	 T	 cells	 in	
different	segments	of	the	intestine	correlate	with	macrophage	numbers45.	IL1b	produced	by	
mucosal	 macrophages	 may	 play	 a	 similar	 role	 in	 promoting	 the	 survival	 of	 local	 IL17	
producing	CD4+	T	cells37	and	in	driving	secretion	of	CSF2	from	type	3	innate	lymphoid	cells	
(ILC3)38.	 Mature	 intestinal	 macrophages	 also	 produce	 a	 number	 of	 chemokines	 that	 can	
recruit	T	cells	and	other	immune	cells,	including	their	own	monocyte	precursors17,20	(Figure	
1A).		
The	high	expression	of	MHCII	by	steady	state	intestinal	macrophages	raises	questions	of	
whether	they	can	behave	as	antigen	presenting	cells	(APCs)	in	vivo.	However	macrophages	
are	 sessile	 in	 the	 mucosa	 and	 do	 not	 migrate	 to	 the	 draining	 mesenteric	 lymph	 node	
(MLN)13.	 Therefore,	 they	are	unlikely	 to	be	 important	 for	priming	naïve	T	 cells,	which	are	
found	only	in	secondary	lymphoid	organs	and	not	the	mucosa.	Whether	macrophages	might	
present	 antigen	 to	 T	 cells	 after	 their	 arrival	 in	 the	 mucosa	 remains	 to	 be	 resolved.	
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Macrophages	may	also	cooperate	with	mucosal	dendritic	cells	during	the	induction	of	local	
immune	 responses	 through	 antigen	 transfer	 to	migratory	 dendritic	 cells46,47.	 Additionally,	
human	 intestinal	 macrophages	 are	 capable	 of	 producing	 retinoic	 acid	 by	 metabolism	 of	
dietary	vitamin	A,	a	property	that	is	restricted	to	intestinal	dendritic	cells	in	mice	and	which	
could	 suggest	 that	 macrophage	 might	 assist	 the	 imprinting	 of	 gut	 homing	 in	 human	 T	
cells48,49.	
	
Are	there	specialised	macrophage	microenvironments	within	the	intestine?	
Much	 of	what	we	 know	 about	 intestinal	macrophages	 comes	 from	 studies	 using	 cells	
isolated	 from	 the	 lamina	 propria	 of	 whole	 tissue	 or	 biopsies.	 Thus	 there	 is	 limited	
information	on	how	macrophages	might	behave	in	the	different	anatomical	compartments	
within	 the	 mucosa.	 There	 are	 relatively	 more	macrophages	 in	 the	 lamina	 propria	 of	 the	
colon	than	the	small	intestine50,	possibly	reflecting	differences	in	the	functions	and	bacterial	
loads	in	these	tissues.		
Macrophages	are	found	in	a	number	of	locations	within	the	mucosa	itself,	ranging	from	
immediately	next	to	the	basement	membrane	underlying	the	epithelium	to	the	central	core	
of	 the	 LP,	 and	 at	 different	 positions	 along	 the	 villus-crypt	 axis	 (Figure	 2A).	 A	 specific	
population	 expressing	 CD169	 is	 found	 near	 the	 crypt	 base,	 close	 to	 the	 submucosa	 and	
these	 may	 have	 distinct	 functions	 and	 developmental	 requirements51,52.	 Substantial	
numbers	 of	macrophages	 are	 also	 found	 in	 the	 external	muscularis	 layer	 of	 the	 intestine	
(Figure	 1A).	 These	 are	morphologically,	 phenotypically	 and	 transcriptionally	 distinct	 from	
those	in	the	lamina	propria,	selectively	expressing	a	number	of	genes	associated	with	tissue	
repair53.	Being	located	close	to	neurons	in	submucosal	ganglia,	they	also	engage	in	two-way	
interactions	 with	 the	 enteric	 nervous	 system	 and	 respond	 to	 luminal	 bacteria	 via	 signals	
from	nor-adrenergic	nerves54,55.	 	 It	 remains	unknown	whether	 the	macrophages	 found	 in	
the	muscularis	 layer	are	derived	 from	different	precursors	 to	 those	 in	 the	 lamina	propria,	
while	the	local	factors	shaping	their	differentiation	are	yet	to	be	elucidated.	
	
Lung	Macrophages.		
The	 lung	 harbours	 at	 least	 two	 different	 macrophage	 populations	 that	 occupy	
distinct	 anatomical	 niches	 (Figure	 1B).	 The	 largest	 of	 these	 inhabits	 the	 alveolar	 space	
(alveolar	 macrophages),	 where	 they	 represent	 ~90-95%	 of	 leukocytes	 and	 reside	 in	 a	
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precisely	defined	niche	on	 the	 luminal	 side	of	 the	 lung	alveoli.	 In	both	mice	and	humans,	
AMs	can	be	 identified	by	 their	high	auto-fluorescence	and	expression	of	CD64,	 as	well	 as	
high	levels	of	CD11c	integrin	and	CD169	(sialoadhesin)	(Table	1)	4,56-58.	However,	important	
phenotypic	differences	exist	between	alveolar	macrophages	in	mice	and	humans	(Table	1).	
For	instance,	although	SiglecF	is	a	signature	molecule	for	mouse	alveolar	macrophages4,	its	
functional	paralog,	Siglec8,	is	absent	from	human	alveolar	macrophages58	(Table	1).	alveolar	
macrophages	develop	 from	 foetal	 liver	monocytes	under	 the	 control	 of	CSF2	 (GM-CSF)	 in	
the	 first	 days	 of	 life,	 paralleling	 the	 development	 of	 the	 alveoli59	 (Figure	 1B)	 and	 then	
maintain	themselves	by	in	situ	self-renewal 57.	
One	of	the	principal	homeostatic	functions	of	alveolar	macrophages	is	regulating	the	
levels	 of	 pulmonary	 surfactant,	 the	 proteolipid	 complex	 synthesised	 and	 secreted	 by	 the	
respiratory	 epithelium	 (Figure	 1B).	 Indeed	 the	 transcriptional	 signature	 of	 alveolar	
macrophages	 features	 several	 genes	 implicated	 in	 lipid	 metabolism4,60	 and	 Pulmonary	
Alveolar	 Proteinosis	 (PAP)	 develops	 due	 to	 excessive	 surfactant	 accumulation	 when	 AM	
development	 is	defective,	 for	 instance	 in	mice	and	humans	 in	whom	 the	CSF2-CSF2R	axis	
has	been	disrupted8.	CSF2	is	predominantly	produced	by	alveolar	epithelial	cells	(AEC)	and	
controls	 much	 of	 the	 unique	 phenotypic	 and	 functional	 identity	 of	 AM,	 including	 lipid	
catabolism	and	cytokine	production	through	induction	of	the	transcription	factor	PPARg61,62.	
Alveolar	 macrophages	 also	 maintain	 the	 integrity	 of	 the	 alveolar	 space	 by	 removing	
senescent	 cells	 and	 inhaled	 particles,	 and	 by	 acting	 as	 a	 first	 line	 of	 defence	 against	
pathogens63.	 Like	 intestinal	 macrophages,	 alveolar	 macrophages	 respond	 poorly	 to	
activation	 by	 TLR	 ligands	 and	 other	 stimuli63,64,	 allowing	 them	 to	 scavenge	 and	 eliminate	
environmental	antigens	in	a	non-phlogistic	manner.	This	hyporesponsive	state	is	maintained	
by	inhibitory	receptors	on	alveolar	macrophages,	including	CD200R,	IL10R	and	TGFbR	which	
recognise	their	respective	ligands	on	AECs.	Binding	of	epithelial-derived	surfactant	proteins,	
of	which	SP-A	and	SP-D	are	the	most	abundant,	to	receptors	such	as	SIRPa	can	also	modify	
phagocytosis,	 cytokine	 production	 and	 TLR	 responsiveness	 of	 alveolar	 macrophages64.	
Aveolar	macrophages	are	also	critical	in	maintaining	airway	tolerance	to	innocuous	antigens	
by	supporting	the	differentiation	of	antigen-specific	Treg66.	Alveolar	macrophages	may	also	
directly	 regulate	 the	 reactivity	 of	 AECs	 to	 their	 environment	 through	 the	 release	 of	
exosomes	and	microvesicles	containing	suppressor	of	cytokine	signalling	(SOCS)	proteins67.	
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Continual	 interaction	with	 the	AEC	 is	 also	 proposed	 to	 account	 for	 alveolar	macrophages	
remaining	 relatively	 sessile	 under	 both	 steady	 state	 conditions	 and	 after	 challenge	 with	
bacterial	stimuli68.		
Macrophages	 are	 also	 found	 in	 the	 lung	 parenchyma	 (interstitium)	 between	 the	
alveoli	and	capillary	beds	(Figure	1B).	These	 interstitial	macrophages	can	be	distinguished	
from	alveolar	macrophages	by	 their	distinct	 surface	phenotype4,56,58,69	 (Table	1)	 and	 they	
have	 a	 unique	 transcriptional	 signature70.	 Similar	 to	 those	 in	 the	 intestine,	 interstitial	
macrophages	 are	MHCII+	 and	 express	 variable	 levels	 of	 CD11c4,58,69,71,	 which	 can	 lead	 to	
their	misclassification	as	DCs.	Because	different	investigators	have	used	divergent	criteria	to	
define	IMs,	there	is	limited	understanding	of	their	role	in	lung	homeostasis72-74.	However	a	
prominent	feature	of	IMs	is	their	constitutive	production	of	the	anti-inflammatory	cytokine	
IL1073,74,	which	is	reported	to	control	the	immunogenicity	of	lung	DCs73.	Furthermore,	they	
produce	growth	factors	such	as	PDGFb	that	are	known	to	regulate	fibroblast	proliferation75.	
Although	 the	 developmental	 origin	 of	 interstitial	 macrophages	 remains	
controversial69,70,76,77,	 they	 have	 been	 shown	 to	 require	 replacement	 by	 monocytes,	
suggesting	 that	different	anatomical	niches	 in	 the	same	tissue	use	distinct	mechanisms	to	
maintain	their	macrophage	populations69,70,76.	Although,	this	may	simply	reflect	differences	
in	 niche	 accessibility.	 For	 instance,	 whereas	 monocytes	 can	 easily	 access	 the	 lung	
parenchyma,	 entry	 to	 the	 alveolar	 space	 under	 normal	 physiological	 conditions	 may	 be	
impeded	by	the	epithelial	barrier8.	
Skin	macrophages.		
The	skin	consists	of	two	anatomically	distinct	regions,	the	dermis	and	the	epidermis,	
each	 of	 which	 contains	 phenotypically,	 developmentally	 and	 functionally	 distinct	
macrophage	populations	(Figure	2A).		
Langerhans	 cells	 are	 found	 in	 the	 stratified	 squamous	epithelium	of	 the	epidermis	
and	express	 the	 langerin	molecule	 (CD207;	see	Table	1)	 responsible	 for	 the	 formation	the	
characteristic	 Birbeck	 granules	 found	 exclusively	 in	 Langerhans	 cells78.	 For	 many	 years,	
Langerhans	 cells	 were	 considered	 the	 archetypal	 non-lymphoid	 dendritic	 cells,	 but	 it	 is	
increasingly	 clear	 that	 they	 display	 features	 of	 both	 macrophages	 and	 dendritic	 cells79		
(Figure	 3A).	 As	 well	 as	 fulfilling	 classical	 dendritic	 cell	 functions,	 such	 as	 migration	 to	
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draining	LNs	and	antigen	presentation79,	mouse	Langerhans	cells	express	high	levels	of	the	
DC-specific	 transcription	 factor	 Zbtb4680	 and	 lack	 expression	 of	 the	macrophage	markers	
CD64	 and	 MerTK79.	 Despite	 this,	 they	 can	 be	 distinguished	 from	 conventional	 type-2	
dendritic	cells	(cDC2s)	based	on	their	expression	of		CD24	and	lack	of	expression	of	CD2681	
(Table	1).	Unlike	dendritic	cells,	Langerhans	cells	are	derived	from	foetal	 liver	monocytes7,	
can	exist	autonomously	from	blood	monocytes	through	in	situ	self-renewal	and	express	the	
macrophage-restricted	 transcription	 factor	 MafB80.	 However	 significant	 differences	 exist	
between	 murine	 and	 human	 Langerhans	 cells	 (Table	 1),	 with	 the	 latter	 sharing	
characteristics	with	mouse	cDC1s,	including	machinery	for	cross	presentation	of	antigens82.	
Unlike	most	other	tissue	macrophages,	Langerhans	cells	rely	on	the	alternative	CSF1R	ligand,	
IL34,	 for	 their	 development,	 which	 is	 produced	 constitutively	 by	 keratinocytes83,84.	
Keratinocyte-derived	 TGFb	 is	 also	 indispensable	 for	 Langerhans	 cell	 development	 and	
maintenance85	(Figure	2A).		
Given	 their	 ability	 to	 migrate	 to	 the	 draining	 lymph	 nodes	 and	 act	 as	 antigen	
presenting	cells,	Langerhans	cells	have	been	 implicated	 in	 initiating	 immune	responses.	As	
discussed	 below,	 this	 can	 involve	 priming	 of	 effector	 T	 cells	 in	 the	 context	 of	 infection.	
However	 in	steady	state	conditions,	 they	may	have	an	 intrinsically	tolerogenic	role86,	with	
increased	 contact	 hypersensitivity	 to	 haptens	 having	 been	 described	 in	 mice	 lacking	
Langerhans	cells87.		Thus	Langerhans	cells	may	be	similar	to	other	dendritic	cell-like	antigen	
presenting	cells	in	being	able	to	adapt	flexibly	to	the	needs	of	their	environment.	
The	 macrophage	 compartment	 of	 the	 underlying	 dermis	 is	 heterogeneous79	 and	
these	 macrophages	 are	 phenotypically	 distinct	 from	 their	 epidermal	 neighbours	 in	 both	
mice	and	humans	(Table	1)88	(Figure	3A).	Notably,	mature	dermal	macrophages	in	mice	can	
be	 either	 MHCII+	 or	 MHCII-,	 and	 although	 the	 relationship	 between	 these	 phenotypic	
subsets	remains	unclear,	they	display	differences	in	transcriptome	and	turnover	kinetics76,88.	
Dermal	macrophages	develop	 initially	 from	embryonic	progenitors,	but	as	 in	the	 intestine,	
these	 are	 displaced	 progressively	 by	 bone	 marrow-derived	 monocytes89.	 Adult	 dermal	
MHCII+	macrophages	 then	 require	 continuous	 replenishment	 from	circulating	monocytes88	
(Figure	2A),	in	a	process	influenced,	in	part,	by	the	microbiota88.	Apart	from	a	clear	role	of	
CSF1R	 signalling90,	 to	 date,	 little	 is	 known	 regarding	 the	 factors	 involved	 in	 dermal	
macrophage	 differentiation.	Whether	MHCII-defined	 subsets	 exist	 in	 human	 skin	 remains	
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unclear,	because	HLA-DR	expression	is	often	used	as	the	starting	point	for	identifying	MPs	in	
human	skin91,92.	Although	dermal	macrophages	are	poor	antigen	presenting	cells88,	as	in	the	
intestine	 they	may	help	maintain	 the	dermal	T	cell	 compartment91,	possibly	 through	their	
constitutive	 production	 of	 IL1088	 (Figure	 2A).	 They	 have	 also	 been	 proposed	 to	 act	 as	
sentinels	 of	 invasion,	 expressing	 a	 number	 of	 genes	 associated	 with	 killing	 of	
microorganisms	and	displaying	avid	phagocytic	ability88.		
	
Liver	macrophages.		
Although	 not	 always	 thought	 of	 as	 a	 barrier	 tissue,	 the	 liver	 receives	 all	 blood	
draining	the	intestine	via	the	portal	vein	and	is	thus	continually	exposed	to	products	of	both	
the	diet	and	the	microbiota.	Kupffer	cells	are	the	principal	macrophages	of	the	liver,	where	
they	reside	in	the	sinusoids,	in	a	perfect	position	to	monitor	materials	emanating	from	the	
intestine	(Figure	2B).	Kupffer	cells	develop	during	embryogenesis	 from	yolk	sac	precursors	
and	 fetal	 liver	 monocytes,	 which	 then	 self-renew	 throughout	 life7.	 However,	 circulating	
monocytes	have	also	been	shown	to	contribute	(albeit	at	low	levels)	to	the	Kupffer	cell	pool	
during	liver	growth	in	the	first	few	weeks	of	life93	and	HSC-derived	cells	may	also	contribute	
to	 the	 Kupffer	 cell	 pool	 with	 age94	 (Figure	 2B).	 The	 precise	 signals	 driving	 Kupffer	 cell	
differentiation	remain	unknown,	but	seem	likely	to	be	derived	from	the	hepatic	cells	in	close	
proximity	 to	 the	 Kupffer	 cells	 such	 as	 liver	 sinusoidal	 endothelial	 cells,	 hepatocytes	 or	
hepatic	 stellate	 cells8.	 As	 well	 as	 generic	 macrophage	 markers,	 Kupffer	 cells	 express	
intermediate	 levels	of	CD11b	and	MHCII,	distinguishing	 them	 from	other	CD11bhi	myeloid	
cells	 in	 the	 liver93	 (Table	 1).	 In	 addition,	 mouse	 Kupffer	 cells	 express	 high	 levels	 of	 the	
phagocytic	 receptor	Tim493,95,	 the	complement	 receptor	VSIG4	 (or	CRIg)96,97	 and	uniquely	
among	 tissue	 macrophages,	 the	 C-type	 lectin	 Clec4F23,93,98	 (Table	 1).	 Human	 hepatic	
macrophages	 express	 CD68,	 CD64	 and	 CD16399,100,	 but	 whether	 these	 markers	 are	
restricted	 to	 Kupffer	 cells,	 or	 are	 also	 present	 on	 other	 liver	 mononuclear	 phagocytes	 is	
unclear.	 Notably,	 although	 Clec4F	 is	 not	 conserved	 in	 humans,	 both	 VSIG4	 and	 Tim4	 are	
expressed	by	human	Kupffer	cells96	(Scott,		Guilliams	Unpublished	observations)	(Table	1).			
Kupffer	 cells	 have	 been	 suggested	 to	 act	 as	 a	 firewall	 preventing	 systemic	
dissemination	of	microbes	and	their	products	from	the	intestine101,102	(Figure	2B).	The	liver	
has	 been	 particularly	 associated	 with	 the	 induction	 of	 tolerance	 to	 orally	 administered	
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proteins103	and	administration	of	antigen	into	the	portal	vein	has	been	reported	to	induce	
systemic	 tolerance,	while	 portal	 vein	 shunting	 abrogates	 oral	 tolerance104-107.	 Given	 their	
phagocytic	capacity	and	their	expression	of	MHCII,	Kupffer	cells	have	been	suggested	to	be	
key	 to	 this	 process,	 both	 as	 antigen	 presenting	 cells108-111	 and	 by	 regulating	 the	 local	
immune	 environment	 via	 the	 production	 of	 immunosuppressive	 cytokines	 including	 IL10	
and	TGFb112,113.	 The	normally	 tolerogenic	 properties	 of	 Kupffer	 cells	 however,	 have	been	
suggested	to	be	overridden	by	stimuli	such	as	TLR	ligands,	suggesting	they	could	also	play	a	
role	in	active	immunity	against	microbial	infections114-116,	however,	whether	this	represents	
true	 Kupffer	 cell	 plasticity	 or	 the	 presence	 of	 non-Kupffer	 cells	 which	 respond	 to	 TLRs	
remains	to	be	investigated.		
Kupffer	 cells	 also	 play	 important	 homeostatic	 roles	 in	 iron	 metabolism	 and	
recycling117,	 and	 they	 express	 a	 number	 of	 genes	 involved	 in	 these	 processes,	 including	
Cd163,	 Slc40a1,	 Hmox1,	 Hpx	 and	 Scd193	 (Figure	 2B).	 These	 properties	 are	 shared	 with	
splenic	red	pulp	macrophages,	which	are	also	exposed	constantly	to	blood95,118.	Stimulation	
of	iron	metabolism	in	Kupffer	cells	by	IL6	and	IL1	can	contribute	to	control	of	infection	via	
deprivation	of	iron	from	pathogens119.	Indeed,	patients	with	a	deficiency	in	hepicidin,	which	
induces	 the	 expression	 of	 a	 number	 of	 proteins	 involved	 in	 iron	 scavenging	 and	
sequestration	 in	 Kupffer	 cells,	 are	 more	 susceptible	 to	 infection	 with	 iron-dependent	
microbes120-122.	 The	Kupffer	 cell	 transcriptome	 is	 also	enriched	 for	 genes	 involved	 in	 lipid	
metabolism93	 and	 Kupffer	 cells	 have	 been	 implicated	 in	 the	 pathogenesis	 of	 diseases	
associated	 with	 excessive	 lipid	 consumption,	 including	 non-alcoholic	 fatty	 liver	 disease	
(NAFLD)	and	non-alcoholic	steatohepatitis	(NASH)123-125	(see	below).					
	 	
Tissue	macrophages	under	non-steady	state	conditions	
One	 of	 the	 most	 important	 gaps	 in	 our	 current	 knowledge	 of	 tissue-resident	
macrophages	is	that	the	study	of	their	behaviour	under	non-homeostatic	conditions	such	as	
infection	and	 inflammatory	disease	 remains	 in	 its	 infancy	 (Box	1	and	Figure	3).	Below	we	
review	 what	 is	 known	 about	 barrier	 tissue	 macrophages	 under	 these	 circumstances,	
focusing	 on	 work	 that	 is	 compatible	 with	 the	 recent	 advances	 in	 understanding	 their	
phenotype	and	biology.		
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Intestinal	Macrophages	
Intestinal	 disorders	 such	 as	 IBD	 and	 infection	 are	 accompanied	 by	 intense	
infiltration	 with	 macrophages	 and	 monocytes126.	 The	 success	 of	 anti-TNFa	 therapy	 in	
Crohn’s	 disease	 highlights	 the	 practical	 relevance	 of	 understanding	 the	 underlying	
immunological	 processes.	 In	 both	 humans	 and	 animals,	 the	majority	 of	 the	 infiltrate	 in	
inflamed	 mucosa	 is	 made	 up	 of	 monocytes	 and	 immature	 macrophages,	 while	 the	
numbers	 of	 mature	 macrophages	 are	 usually	 normal,	 or	 even	 reduced	 compared	 with	
steady	 state	 intestine14,15,21,127.	 Furthermore,	 the	 relatively	 immature	 cells	 account	 for	
most	 of	 the	 pro-inflammatory	 mediators	 such	 as	 IL1,	 IL6,	 TNFa,	 IL23,	 NO	 and	 ROI14-
18,127,128.	 As	 well	 as	 causing	 tissue	 damage	 and/or	 targeting	 microbes	 directly,	 these	
mediators	can	also	activate	other	effector	cells	of	the	innate	and	adaptive	immune	system,	
such	 as	 monocytes,	 neutrophils,	 Th17	 cells	 and	 Th1	 cells.	 Pro-inflammatory	
monocytes/macrophages	also	produce	chemokines	such	as	CCL2,	CCL3,	CCL4,	CCL5,	CCL8	
and	CCL11	which	recruit	eosinophils	and	neutrophils,	as	well	as	more	monocytes51,129,130.	
As	 in	 steady	 state	 intestine,	 the	 enhanced	 recruitment	 of	 monocytes	 into	 inflamed	
intestine	 is	 driven	mostly	 by	 CCR2126,131,	 although	 other	 chemokine-receptors	may	 also	
contribute,	such	as	CCL3	and	its	receptor	CCR1132.		
The	 monocytes	 that	 infiltrate	 the	 inflamed	 mucosa	 of	 humans	 and	 mice	 are	
phenotypically	indistinguishable	from	those	which	replenish	the	mature	macrophage	pool	
under	steady	state	conditions.	However	their	development	appears	to	be	arrested	before	
they	acquire	significant	anti-inflammatory	properties	such	as	production	of	 IL10	or	hypo-
responsiveness	to	stimulation14-16.	The	reasons	for	this	block	in	differentiation	are	unclear,	
although	one	possibility	could	be	that	 the	monocytes	recruited	to	the	 inflamed	 intestine	
are	 already	 intrinsically	 different.	 A	 process	 of	 this	 kind	 has	 been	 found	 in	 murine	
Toxoplasmosis,	 where	 IL12	 released	 from	 the	 inflamed	 mucosa	 alters	 monocyte	
differentiation	in	the	BM	via	the	production	of	IFNg133,	but	this	has	not	yet	been	explored	
in	other	contexts.		
It	 is	 controversial	 whether	 the	 original	 fully	 mature	 macrophages	 also	 contribute	 to	
intestinal	inflammation	(Box	1	and	Figure	3).	Although	mature	resident	macrophages	do	not	
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become	pro-inflammatory	during	experimental	colitis	induced	by	chemicals	or	T	cells14,16,18,	
this	can	occur	under	conditions	when	inflammation	occurs	in	the	absence	of	IL10	mediated	
control	 of	 macrophage	 activity21,128.	 One	 population	 of	 resident	 macrophages	 that	 may	
contribute	 directly	 to	 inflammation	 is	 that	 expressing	 CD169,	 which	 recruits	 monocyte	
neutrophils	 via	 production	 of	 CCL851,52.	 	 Furthermore,	 muscularis	 macrophages	 play	
important	roles	in	postoperative	paralytic	ileus	by	producing	nitric	oxide	in	response	to	local	
trauma,	leading	to	activation	of	neighbouring	neurons54.	
Macrophages	 also	 play	 a	 role	 in	 the	 protective	 immunity	 that	 expels	 large	
extracellular	microorganisms	such	as	intestinal	helminths134,135.	During	such	Th2	responses,	
macrophages	 produce	 arginase	 and	 RELMa135,136,	 together	 with	 chemokines	 that	 can	
recruit	eosinophils	and	other	effector	cells130.	This	generates	an	environment	detrimental	to	
parasite	survival,	encouraging	their	expulsion.	As	in	other	forms	of	intestinal	inflammation,	
newly	 recruited	monocytes	 seem	 to	 be	 the	most	 important	 source	 of	 activated,	 effector	
macrophages	 in	 these	 Th2-dependent	 immune	 responses135.	 However	 as	 IL4	 dependent	
local	proliferation	and	activation	of	pre-existing	resident	macrophages	has	been	described	
in	 parasite	 infection	 of	 the	 serous	 cavities137,	 similar	 processes	 might	 be	 feasible	 in	 the	
intestine.	
Macrophages	 are	 important	 for	 tissue	 repair	 and	 restoration	 of	 homeostasis	 after	
inflammation	 in	 the	 intestine.	 This	 may	 involve	 their	 ability	 to	 drive	 epithelial	 stem	 cell	
renewal32,138,	while	IL1-mediated	induction	of	IL22	from	ILC3	helps	restore	epithelial	barrier	
function	 and	 has	 anti-microbial	 effects131,139.	 Macrophages	 may	 also	 protect	 against	
intestinal	 inflammation	 induced	 by	 the	 chemical	 DSS	 by	 suppressing	 production	 of	 the	
alarmin	 IL33140,	 while	 their	 ability	 to	 produce	 arginase	 during	 Th2	 mediated	 immune	
responses	is	a	crucial	component	of	tissue	repair	after	helminth	infection141,142.	As	a	result	
of	 these	 properties,	 depletion	 of	 macrophage	 delays	 recovery	 from	 experimental	
colitis138,140,143.	Whether	these	are	functions	of	pre-existing	resident	macrophage	or	of	the	
monocytes	 recruited	during	 the	 initial	 pathology	 is	 again	unclear,	 although	 recent	 studies	
have	 shown	 that	 apparently	 pro-inflammatory	 monocytes	 recruited	 during	 murine	
Toxoplasmosis	 may	 protect	 against	 immunopathology	 by	 producing	 PGE2	 supressing	
neutrophil	 activation127.	 Both	 GM-CSF	 and	 VEGF-C	 produced	 during	 inflammation	 have	
been	shown	to	induce	reparative	properties	in	intestinal	macrophages144.	
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Lung	Macrophages	
Given	 their	 positioning	 in	 the	 airway,	 it	 is	 unsurprising	 that	 alveolar	macrophages	
are	key	effector	cells	in	the	protective	response	against	bacterial,	viral	and	fungal	infections.	
By	virtue	of	their	expression	of	a	range	of	PRRs	and	high	phagolysosomal	capacity,	alveolar	
macrophages	excel	at	engulfing	and	destroying	extracellular	bacteria	such	as	Streptococcus	
pneumonia63.	 alveolar	 macrophages	 also	 orchestrate	 the	 recruitment	 of	 neutrophils	 and	
effector	monocytes	to	the	lung	through	release	of	IL1b,	which	induces	CXCL8	production	by	
the	respiratory	epithelium145.	They	are	also	potent	producers	of	type	1	 IFN	in	response	to	
viral	 infections	 and	 orchestrate	 the	 recruitment	 of	 anti-viral	 monocytes146.	 Alveolar	
macrophages	enhance	viral	clearance	during	influenza	infection	and	there	is	increased	lung	
pathology	in	systems	in	which	alveolar	macrophages	have	been	depleted64,147.	Conversely,	
the	activation	threshold	of	alveolar	macrophages	may	be	heightened	following	severe	viral	
infection,	 leaving	 individuals	 more	 susceptible	 to	 bacterial	 infections.	 This	 may	 involve	
changes	in	expression	of	inhibitory	ligands	by	AEC	64.	
Alveolar	 macrophages	 have	 also	 been	 implicated	 in	 the	 development	 and	
progression	 of	 asthma,	 although	 it	 remains	 uncertain	whether	 they	 play	 a	 pathogenic	 or	
protective	 role148.	 On	 one	 hand,	 depletion	 of	 alveolar	 macrophages	 in	 mice	 worsens	
allergen-induced	 airway	 inflammation149	 and	 adoptive	 transfer	 of	 normal	 alveolar	
macrophages	 can	 protect	 sensitised	 lungs	 from	 damage149.	 Moreover,	 alveolar	
macrophages	 from	 asthmatic	 patients	 produce	 more	 IL10	 than	 their	 counterparts	 from	
healthy	 lungs150.	 However,	 alveolar	macrophages	 from	 allergen-sensitised	mice	 are	more	
able	 to	 stimulate	 T	 cell	 responses	 and	 alveolar	 macrophages	 from	 asthmatic	 patients	
express	 higher	 levels	 of	 costimulatory	 molecules	 such	 as	 CD80151,	 suggesting	 asthmatic	
alveolar	macrophages	may	be	able	to	promote	pathogenic	Th2	responses,	perhaps	through	
their	production	of	IL13147.		
	 	The	 role	 of	 interstitial	 macrophages	 in	 lung	 inflammation	 or	 infection	 is	 poorly	
understood,	 although	 they	 have	 been	 shown	 to	 confer	 protection	 against	 allergic	 airway	
inflammation	 by	 producing	 IL10152.	 Whether	 this	 is	 a	 property	 of	 resident	 interstitial	
macrophages	 or	 if	 elicited	 monocyte-derived	 macrophages	 can	 also	 do	 this	 is	 unclear.	
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Similarly,	 whether	 interstitial	 macrophage-derived	 IL10	 plays	 an	 important	 role	 in	 other	
models	 of	 disease	 remains	 to	 be	 determined.	 interstitial	 macrophages	 also	 release	 EGF	
which	 has	 been	 suggested	 to	 promote	 alveolar	 fluid	 clearance	 through	 promotion	 of	
epithelial	sodium	channels153.		
	 Pulmonary	 macrophages	 are	 important	 in	 driving	 the	 fibrogenesis,	 matrix	
remodelling	 and	 re-epithelialisation	 of	 the	 alveolar	 wall	 that	 are	 all	 essential	 for	 the	
restoration	 of	 barrier	 integrity	 and	 efficient	 gas	 exchange	 following	 lung	 injury.	 alveolar	
macrophages	 produce	 multiple	 growth	 factors	 that	 promote	 re-epithelialisation	 of	 the	
alveolar	wall,	including	VEGF,	PDGF,	FGF,	TGFb154,155.	TNFa	from	alveolar	macrophages	also	
upregulates	CSF2	production	from	AECs,	stimulating	AEC	proliferation156,157	and	supporting	
alveolar	 macrophage	 maintenance.	 Efferocytosis	 of	 apoptotic	 cells	 also	 promotes	 pro-
reparative	 functions	 of	 alveolar	macrophages,	 including	 the	 production	 of	 PGE2,	 PAF	 and	
TGFb158.	 Somewhat	 paradoxically,	 lung	 macrophages	 have	 been	 implicated	 in	 the	
pathogenesis	 of	 interstitial	 lung	 diseases,	 such	 as	 idiopathic	 pulmonary	 fibrosis	 (IPF)	 in	
which	 there	 is	 uncontrolled	 fibrogenesis.	 The	 relative	 roles	 of	 tissue-resident	 alveolar	
macrophages,	 interstitial	 macrophages	 and	monocyte-derived	 infiltrating	 macrophages	 in	
this	condition	remain	poorly	understood8.	For	instance,	although	alveolar	macrophages	can	
promote	 resolution	 of	 experimental	 bleomycin-induced	 fibrosis159,	 alveolar	 macrophages	
from	IPF	patients	produce	many	pro-fibrotic	mediators	including	TGFb160	and	CCL18161	and	
depletion	 of	 macrophages	 (alveolar	 macrophages	 or	 infiltrating	 macrophages)	 reduces	
fibrogenesis	 in	 the	 same	 model162.	 However,	 this	 could	 be	 explained	 by	 recent	 work	
demonstrating	 that	 origin	 of	 alveolar	 macrophages	 can	 influence	 their	 function.	
Experimental	fibrosis	disrupts	the	autonomous	renewal	of	alveolar	macrophages,	leading	to	
the	 recruitment	 of	 bone	 marrow-derived	 alveolar	 macrophages	 that	 are	 more	 pro-
fibrogenic	than	their	resident	counterparts163.	How	origin	dictates	function	remains	unclear,	
although	 one	 possibility	 is	 that	 resident	 and	 bone	marrow-derived	 alveolar	macrophages	
might	 occupy	 different	 micro-anatomical	 niches	 and	 that	 this	 controls	 their	 function.	 As	
discussed	in	Box	1,	the	roles	of	developmentally-distinct	macrophages	in	other	settings	has	
not	been	examined,	including	during	pulmonary	emphysema	where	macrophages	may	also	
contribute	 to	 loss	 of	 alveolar	 architecture	 through	 their	 enhanced	 production	 of	 matrix	
metalloproteinases	MMP1	and	MMP1264.	
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Skin	Macrophages	
Langerhans	cells	have	been	shown	to	induce	active	Th17	responses	during	cutaneous	
Candida	albicans	 infection164	 and	 can	participate	 in	 effector	 CD8+	 T	 cell	 priming	 in	 lymph	
nodes	during	Herpes	simplex	virus	(HSV)	infection,	either	by	presenting	antigen	directly	to	T	
cells	or	after	transfer	to	cDC1s165,166.	Recently,	it	was	shown	that	CD1a	on	Langerhans	cells	
can	amplify	Th17-driven	models	of	dermatitis	 and	psoriasis167.	 Importantly,	blocking	CD1a	
through	administration	of	anti-CD1a	antibodies	 significantly	 reduced	skin	 inflammation167,	
providing	 a	 putative	 therapeutic	 option	 for	 patients	 with	 Th17	 mediated	 skin	 diseases.	
Although	 phenotypically-distinct	 (MHCIIhi)	 monocyte-derived	 Langerhans	 cells	 have	 been	
shown	to	accumulate	during	models	of	injury/inflammation168,	it	remains	unclear	if	these	or	
pre-existing	resident	cells	are	responsible	for	the	pro-inflammatory	functions	of	Langerhans	
cells	under	these	conditions.		
	
Little	 is	known	regarding	the	roles	of	dermal	macrophages	under	non-homeostatic	
conditions.	 Dermal	monocyte-derived	 cells	 have	 been	 shown	 to	 accumulate	 in	 and	 drive	
development	 of	 psoriasis-like	 inflammation79,168,	 but	 not	 in	 other	 forms	 of	 inflammation	
such	as	contact	allergen	induced	dermatitis88.	Dermal	macrophages	may	play	a	role	 in	the	
first	 line	 of	 defence	 against	 pathogens,	 having	 been	 shown	 to	 induce	 neutrophil	
extravasation	 in	 responses	 to	 local	 infection	 with	 Staphylococcus	 aureus169.	 Dermal	
macrophages	 are	 also	 essential	 for	 wound	 healing	 and	 restoration	 of	 tissue	 integrity	
following	mechanical	 skin	 injury.	 Again	 the	 relative	 contribution	 of	 fully	 mature	 resident	
macrophages	 versus	 elicited	 monocyte-derived	 cells	 is	 unclear,	 but	 macrophages	 are	
essential	 for	 neovascularisation,	 collagen	 fibril	 assembly	 and	 scab	 formation,	 in	 a	 process	
dependent	on	IL4R	signalling170.	IL4/IL13	polarised	dermal	macrophages	are	also	implicated	
in	 driving	 tissue	 fibrosis	 through	 their	 production	 of	 RELMa	 which	 promotes	 pro-fibrotic	
collagen	 crosslinking	 by	 dermal	 fibroblasts170.	 A	 population	 of	 flt3L-dependent,	migratory	
monocyte-derived	dendritic	cells	has	been	reported	in	the	dermis	under	both	homeostatic	
and	 inflammatory	conditions,	but	 the	exact	nature	of	 these	cells	 remains	unclear,	as	does	
their	relationship	to	dermal	macrophages	(Box	1).		
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Liver	Macrophages	
Kupffer	cells	have	been	implicated	in	several	acute	and	chronic	hepatic	pathologies,	
including	ischemia/reperfusion	(I/R-)	injury,	acetaminophen	hepatoxicity	(AILI),	liver	fibrosis,	
alcoholic	 liver	 disease	 (ALD),	 viral	 hepatitis,	 non-alcoholic	 steatohepatitis	 (NASH),	 non-
alcoholic	 fatty	 liver	 disease	 (NAFLD)	 and	 hepatocellular	 carcinoma	 (HCC).	 However	
contradictory	 findings	 have	 been	 reported	 on	 the	 exact	 roles	 of	 Kupffer	 cells	 in	 these	
conditions171.	In	I/R-injury,	for	example,	Kupffer	cells	have	been	attributed	both	pathogenic	
and	 protective	 roles,	 driven	 by	 TNFa,	 IL1b	 and	 reactive	 oxygen	 species	 (ROS)	 and	 IL10	
respectively172-174.	Analogous	findings	have	been	reported	in	viral	hepatitis,	where	Kupffer	
cells	have	been	suggested	to	produce	both	anti-viral	mediators	and	to	suppress	protective	
immunity175.	 These	 contrasting	 conclusions	may	 reflect	 the	 fact	 that	 previous	 studies	 did	
not	distinguish	between	bona	fide	Kupffer	cells	and	infiltrating	monocytes/macrophages,	or	
used	depletion	strategies	that	targeted	all	myeloid	cells	in	the	liver.		
More	recent	studies	have	attempted	to	explore	the	relative	roles	of	these	cell	types	
in	inflammatory	liver	pathology.	Notably,	Kupffer	cells	maintain	their	distinct	transcriptional	
profile	 following	 acetaminophen-induced	 liver	 injury,	 remaining	 largely	 identical	 to	 their	
steady	 state	 counterparts176.	 However,	 as	 the	 damage	 following	 paracetamol	 overdose	 is	
restricted	anatomically,	it	will	be	interesting	to	determine	if	specific	Kupffer	cells	located	in	
the	damaged	areas	do	respond	to	the	injury	and	if	perhaps	this	has	been	overlooked	using	
bulk	 transcriptomic	 techniques.	 Interestingly,	 the	 infiltrating	monocytes/macrophages	 are	
thought	to	both	aggravate	the	early	stages	of	 this	disorder177	and	to	be	necessary	 for	 the	
subsequent	 resolution	 of	 the	 inflammation176.	 Notably,	 recruited	 monocyte-derived	
macrophages	do	not	appear	to	develop	into	bona	fide	Kupffer	cells	under	these	conditions	
rather	generating	 short-lived	macrophages	 176	 (Scott,	Guilliams	unpublished	observations).	
In	 contrast,	 monocyte-derived	 Kupffer	 cells	 can	 be	 found	 during	 Listeria	 monocytogenes	
infection178.	 In	 this	 infection,	 early	 uptake	 of	 bacteria	 triggers	 Kupffer	 cell	 death	 by	
necroptosis	 and	 bacteria	 are	 subsequently	 eliminated	 by	 recruited	 monocyte	 derived	
macrophages	which	later	develop	into	bona	fide	Kupffer	cells178.	However,	it	remains	to	be	
seen	if	Kupffer	cell	death	following	bacterial	uptake	is	required	for	the	effective	clearance	of	
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the	bacteria	and	return	to	liver	homeostasis,	furthermore,	the	impact	of	macrophage	origin	
on	these	functions	requires	further	study	(Box	1).	Thus	there	is	still	much	to	learn	regarding	
the	specific	 functions	of	Kupffer	cells	and	recruited	monocyte-derived	macrophages	 in	the	
liver	under	non-homeostatic	 conditions.	The	use	of	 the	newly	defined	markers	capable	of	
discriminating	between	Kupffer	 cells	 and	other	 recruited	monocyte-derived	macrophages,	
as	 well	 as	 investigating	 differences	 in	 micro-anatomical	 location,	 will	 be	 critical	 to	 truly	
assess	macrophage	function	during	these	pathologies.		
	
Summary	and	Future	Perspectives		
Many	of	the	central	dogmas	about	the	origin	and	function	of	macrophages	in	barrier	
tissues	have	been	completely	revised	in	recent	years,	with	an	increasing	awareness	of	their	
heterogeneity	 and	 diversity	 of	 physiological	 roles.	 Rather	 than	 depending	 on	 their	 origin,	
the	properties	of	macrophages	are	highly	tissue	specific	and	appear	to	be	imprinted	locally,	
ensuring	precise	 adaptation	 to	 the	demands	of	 their	 environment.	 These	properties	offer	
clear	 possibilities	 for	 targeted	 therapeutic	 intervention,	 with	 the	 aim	 of	 restoring	
homeostasis.	 However	 for	 this	 to	 be	 achieved,	 the	 factors	 driving	 the	 specification	 of	
different	 tissue-resident	macrophage	populations	under	homeostatic	 conditions	would	be	
crucial	 to	 identify.	 Determining	 the	 relative	 roles	 played	 by	 resident	 and	 infiltrating	
macrophages	during	 infection	or	 inflammation	could	create	further	options	for	preventing	
their	recruitment	or	activation.	
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Box	1:	Macrophage	behaviour	under	non-homeostatic	conditions	
Disruption	 of	 local	 homeostasis	 due	 to	 inflammation	 or	 infection	 results	 in	 a	
drastically	altered	local	environment,	with	damage	to	tissue	cells	and	induction	of	an	innate	
immune	 response.	 These	 lead	 to	 increased	 production	 of	 inflammatory	 cytokines	 and	
chemokines,	 together	 with	 recruitment	 of	 inflammatory	 cells	 including	 neutrophils	 and	
monocytes,	 the	 latter	 of	 which	 can	 differentiate	 into	 macrophages.	 An	 important	
unanswered	 question	 concerns	 the	 relative	 roles	 of	 newly	 recruited	 and	 pre-existing	
macrophages	 in	 inflammation	 (Figure	3).	Although	 it	 is	clear	 that	 recruited	monocytes	are	
sufficiently	 plastic	 to	 respond	 appropriately	 to	 the	 changing	 environment,	 there	 is	 less	
evidence	 that	 the	 tissue-resident	macrophages	 can	modify	 their	 homeostatic	 functions	 to	
become	 pro-inflammatory	 under	 such	 circumstances.	 Indeed	 the	 findings	 that	 the	 tissue	
conditioned	 properties	 of	 resident	 macrophages	 are	 determined	 at	 the	 level	 of	 the	
epigenome23	would	suggest	it	may	be	difficult	for	these	cells	to	change	in	response	to	new	
triggers,	although	this	 too	 is	 likely	 to	be	tissue-specific.	 Importantly	 there	 is	evidence	that	
pre-existing	 tissue-resident	 and	 newly	 recruited	 inflammatory	 macrophages	 can	 respond	
differently	to	stimuli,	at	least	in	the	peritoneal	cavity,	lung	and	liver163,178,179.	This	has	clear	
implications	for	designing	macrophage-targeted	therapy	in	inflammation.		
In	 many	 tissues,	 inflammation	 is	 associated	 with	 a	 reduction	 in	 the	 resident	
macrophage	population,	often	referred	to	as	the	‘macrophage	disappearance	reaction’.	The	
mechanisms	 responsible	 are	 likely	 to	 be	 specific	 to	 each	 inflammatory	 insult,	 but	 could	
include	cell	death,	 increased	adherence	to	tissue	stroma,	or	emigration	from	the	tissue.	A	
controversial	 topic	 is	whether	monocytes	and/or	macrophages	can	migrate	 from	 inflamed	
tissues	to	draining	lymph	nodes	and	present	antigen	to	T	cells,	thus	behaving	as	“monocyte-
derived	dendritic	cells”.	This	is	a	longstanding	concept	in	myeloid	cell	biology	and	although	
macrophages	 do	 not	 migrate	 to	 lymph	 nodes	 under	 steady	 state	 conditions,	 during	
inflammation	 in	 tissues	 such	as	 the	gut	and	 lung,	 some	monocytes	may	upregulate	CCR7,	
migrate	 to	 draining	 lymph	 nodes	 and	 present	 antigen	 to	 naïve	 T	 cells180.	 As	 these	 cells	
express	 MafB,	 but	 not	 Zbtb46,	 they	 appear	 to	 be	 macrophages	 rather	 than	 part	 of	 the	
genuine	 dendritic	 cell	 lineage80.	 Although	 this	 is	 likely	 a	 relatively	 rare	 process,	 it	 would	
clearly	 be	 an	 effective	way	of	 expanding	 the	 range	of	 antigen	presenting	 cells	 capable	 of	
driving	 effector	 T	 cell	 responses	 in	 protective	 immunity	 and	 underlines	 the	 plasticity	 of	
recruited	monocytes.	
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During	 recovery	 from	 inflammation	 or	 infection,	 the	 macrophage	 population	
typically	 returns	 to	steady	state	 levels	and	can	also	contribute	to	the	restoration	of	 tissue	
homeostasis.	 Again	 it	 is	 unclear	 if	 these	 processes	 reflect	 differentiation	 of	 the	 recruited	
inflammatory	 monocytes/macrophages	 into	 macrophages	 with	 repair	 functions	 or	 via	 a	
second	wave	of	monocyte	 recruitment	and	macrophage	differentiation.	 Similarly,	 it	 is	not	
known	 if	 the	 replenishment	 of	 macrophage	 numbers	 occurs	 through	 proliferation	 of	 the	
remaining	 resident	macrophage	 population	 or	 additional	 recruitment	 of	monocytes,	 or	 a	
combination	of	these	processes	(Figure	3).		
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Figure	Legends	
	
Figure	 1:	 Barrier	 tissue	macrophage	 function	 under	 homeostatic	 conditions.	A)	Resident	
macrophages	 in	 the	 lamina	 propria	 (LP)	 of	 the	 intestine	 express	 high	 levels	 of	 many	
receptors	for	apoptotic	cells,	ideal	for	clearing	the	large	amounts	of	cell	death	found	in	this	
rapidly	turning	over	tissue14,18-22.	Production	of	trophic	factors	for	epithelial	stem	cells	and	
tissue	remodelling	metalloproteinases	helps	maintain	barrier	 integrity20,28-34.	Being	actively	
phagocytic	 and	 bactericidal,	 lamina	 propria	 macrophages	 are	 crucial	 in	 shaping	 host-
microbiota	 symbiosis	 and	 may	 send	 processes	 across	 the	 epithelial	 barrier	 to	 sample	
contents	 of	 the	 lumen.	 They	 acquire	 many	 antigens	 avidly	 and	 pass	 these	 on	 to	
neighbouring	migratory	dendritic	cells	for	presentation	to	T	cells	in	the	draining	mesenteric	
lymph	 node46,47.	 Intestinal	 macrophages	 in	 adults	 are	 replenished	 continuously	 by	
circulating	Ly6Chi	monocytes14,16,25.	These	differentiate	locally	via	a	number	of	intermediary	
stages	 in	 the	 so-called	 “monocyte	 waterfall”	 under	 the	 control	 of	 environmental	 signals	
such	as	TGFb20,	a	process	associated	with	the	expression	of	the	transcription	factors	RUNX3	
and	KLF10	 (Ref.	23).	The	 inability	of	mature	 intestinal	macrophages	 to	respond	to	pattern	
recognition	 receptor	 triggering	 is	 controlled	 by	 IL10	 (Refs	 21,	 41-43).	 Constitutive	
production	of	 IL10	 and	other	 cytokines	 sustains	 the	 survival	 of	 other	 immune	 cells	 in	 the	
vicinity,	 including	 FoxP3+	 Treg35,44	 and	 type	 3	 innate	 lymphoid	 cells	 (ILC3)	 (Ref.	 38),	 while	
release	of	chemokines	such	as	CCL2	allows	the	macrophages	to	recruit	their	own	monocyte	
precursors	and	other	leukocytes17,20.	Macrophages	in	the	muscularis	mucosa	are	involved	in	
two-way	interactions	with	sympathetic	neurons	of	the	enteric	nervous	system	and	express	
high	 levels	 of	 the	 b2	 adrenergic	 receptor	 (b2AR)53,54.	 Signalling	 through	 the	 b2AR	 drives	
anti-inflammatory	and	pro-repair	properties	 in	 the	macrophages,	 including	 the	production	
of	 IL10	 and	 RELMa,	 while	 bone	 morphogenic	 protein	 2	 (BMP2)	 produced	 by	 muscularis	
macrophages	 in	 response	 to	microbial	 signals	 regulates	neuronal	 function53,54.	 B)	Alveolar	
macrophages	 (AMs)	 in	 the	 lung	 are	 crucial	 for	maintaining	patency	of	 the	 alveolar	 space,	
where	 they	 regulate	 surfactant	 levels	 and	 phagocytose	 inhaled	 microbes	 and	 other	
particulate	 materials59,61.	 They	 communicate	 intimately	 with	 alveolar	 epithelial	 cells,	
removing	dead	cells	and	controlling	their	renewal.	Alveolar	macrophages	maintain	an	anti-
inflammatory	 environment	 via	 expression	 of	 inhibitory	 cytokines	 and	 receptors	 that	
regulate	 T	 cell	 responses	 and	 local	 innate	 immune	 reactions.	 Alveolar	 macrophages	 are	
derived	 from	 foetal	 liver	 monocytes	 during	 the	 neonatal	 period	 that	 subsequently	 self-
renew	 for	 much	 of	 adult	 life57,59.	 Alveolar	 macrophage	 differentiation	 is	 driven	 by	 CSF2	
acting	by	 inducing	 the	expression	of	 the	TF	PPARg59,61,62,	whose	 ligands	may	 include	 lipid-
rich	materials	such	as	surfactant	present	in	the	alveolar	space.	Other	TFs	involved	in	alveolar	
macrophage	development	include	Bach2	and	C/EBPb181,182.	The	specific	functions	of	steady	
state	interstitial	macrophages	(IMs)	are	not	yet	known,	but	may	include	second	line	defence	
against	 microbes,	 promotion	 of	 anti-inflammatory	 T	 cell	 responses	 and	 shaping	 local	
dendritic	 cell	 functions73.	 The	 origin(s)	 of	 interstitial	 macrophages	 	 remain	
controversial69,70,76,77	and	the	signals	and	transcription	factors	involved	in	their	specification	
are	yet	to	be	determined.		
	
Figure	2:	Barrier	tissue	macrophage	function	under	homeostatic	conditions.	A)	Langerhans	
cells	 (LCs)	 in	 the	 epidermis	 have	 transcriptional	 and	 functional	 properties	 of	 both	
macrophages	and	dendritic	cells79,80.	They	are	highly	phagocytic	and	proficient	at	acquiring	
antigen	 from	 the	 environment,	 but	 can	 also	 transport	 this	 to	 draining	 lymph	 nodes	 and	
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present	it	to	T	cells,	helping	to	maintain	tolerance	in	the	steady	state.	Langerhans	cells	are	
derived	from	yolk	sac	precursors	and	foetal	liver	monocytes77,	89,	and	their	differentiation	is	
regulated	by	 TGFb85	 and	 the	CSF1R	 ligand	 IL34	 (Refs.	 83),	 together	with	 the	 transcription	
factors	 AhR	 and	 RUNX3.	 Dermal	 macrophages	 appear	 to	 contain	 descendants	 of	 both	
embryonic	precursors	and	Ly6Chi	monocytes,	with	the	latter	being	dominant	in	adult	life88,	
but	the	factors	 involved	 in	their	differentiation	and	their	tissue-specific	roles	remain	to	be	
determined.	 B)	 Kupffer	 cells	 are	 located	 at	 the	 intersection	 of	 the	 enteric	 and	 peripheral	
circulatory	systems.	Thus	they	are	in	an	ideal	position	to	act	as	a	firewall	against	microbes	
and	other	 factors	arriving	 from	the	 intestine	 in	 the	portal	veins101,102,	and	they	have	been	
implicated	in	maintaining	tolerance	to	these	materials,	either	directly	by	presenting	antigen	
to	 T	 cells,	 or	 by	maintaining	 an	 immunosuppressive	 local	 environment103-114.	 Kupffer	 cells	
play	a	crucial	role	in	recycling	of	iron	from	senescent	red	blood	cells	and	are	also	involved	in	
metabolism	 of	 lipids	 and	 transport	 of	 the	 resulting	 products	 into	 bile95,117.	 As	 they	 are	
closely	 associated	 with	 other	 parenchymal	 cells	 such	 as	 hepatocytes	 and	 liver	 sinusoidal	
endothelial	cells	(LSECs),	it	is	likely	that	Kupffer	cells	may	be	important	in	the	homeostasis	of	
these	cell	 types8.	Kupffer	cells	develop	 from	foetal	 liver	monocyte	precursors89	and	this	 is	
driven	 by	 heme	 derived	 from	 the	 recycling	 of	 effete	 red	 blood	 cells95,	 together	with	 the	
transcription	factor	Id3	183.	Additional,	as	yet	unidentified,	signals	are	likely	to	be	involved	in	
the	specification	of	all	these	tissue-resident	macrophage	populations.		
	
	
Figure	3:	Macrophages	in	barrier	tissues	under	non-homeostatic	conditions.	Disruption	of	
homeostasis	by	infection	or	inflammation	leads	to	the	recruitment	of	Ly6Chi	monocytes	and	
other	 inflammatory	 leukocytes	such	as	neutrophils	and	eosinophils.	The	Ly6Chi	monocytes	
generate	inflammatory	macrophages	and	together,	these	are	the	main	sources	of	mediators	
such	as	TNFa,	 IL1	and	IL6	(Refs.	17,	176).	 It	appears	that	most	of	these	monocytes	do	not	
differentiate	 into	 fully	mature	macrophages	 as	 they	would	under	homeostatic	 conditions,	
due	 to	 an	 arrest	 in	 this	 process	 and	 so	 these	 inflammatory	 cells	may	be	 short-lived14.	 An	
additional	 source	 of	 pro-inflammatory	 macrophages	 during	 inflammation	 may	 be	
monocytes	whose	properties	have	already	been	programmed	differently	before	leaving	the	
bone	marrow	 in	 response	 to	 signals	 generated	 in	 the	 inflamed	 tissue133.	 The	 role	 of	 the	
original	tissue	resident	macrophage	population	in	inflammation	remains	unclear.	They	may	
act	 as	 early	 sentinels	 of	 tissue	 damage	 and	 recruit	 monocytes	 and	 granulocytes	 via	
production	of	CCL2,	CCL8,	CCL11,	CXCL2	and	other	chemokines.	However	 in	many	tissues,	
the	numbers	of	resident	macrophages	are	often	reduced	during	the	immediate	response	to	
tissue	 injury,	 the	 so-called	 macrophage	 disappearance	 reaction.	 Whether	 the	 remaining	
cells	 can	 alter	 their	 normal	 anti-inflammatory	 properties	 to	 contribute	 to	 pathology	 and	
protective	immunity	is	not	fully	understood	and	may	depend	on	the	circumstances	or	tissue	
involved14,17,137,146,163,	168,176.	Many	questions	also	remain	unanswered	regarding	the	fate	of	
the	monocytes	 and	macrophages	 upon	 return	 to	 homeostasis.	 For	 example,	 do	 activated	
tissue-resident	 macrophages	 return	 to	 steady	 state?	 Do	 the	 recruited	 monocyte-derived	
macrophages	 die,	 persist	 in	 the	 tissue	 as	 monocyte-derived	 macrophages	 or	 become	
monocyte-derived	tissue	resident	macrophages?	Finally,	it	is	unclear	if	additional	monocytes	
are	recruited	to	help	replenish	the	resident	macrophage	niche	and	how	each	of	these	cells	
might	contribute	to	the	tissue	repair	process.	
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Table	1:	Surface	Markers	of	Major	Macrophage	Subsets	in	Barrier	Tissues.	
	
Tissue	
Macrophage	
Subset	 Surface	Phenotype	
	
Mouse	 Human	 References	
Intestine	 Lamina	Propria	
CD64+	SIRPa+	
MHCII+	CD163+	
CD68+	
F4/80+	
MerTK+	CD11b+	
CX3CR1hi	
CD11c+/–	
CD206+	
Tim4+/–	avb5+	
CD36+	
CD64+	SIRPa+	
HLA-DR+	CD163+	
		
		
14,16-20,22,81	
Lung	
Alveolar	
CD64+	F4/80+	
MerTK+	SIRPa+	
CD11b–	MHCII–	
CX3CR1–	CD11chi	
SiglecF+	CD169+	
CD206+	CD163–	
CD64+	CD11b+	
HLA-DR+	CD163+	
Siglec8–	CD169+	
	
57,58,81,184	
Interstitial	
CD64+	CD14+	
MHCII+	SIRPa+	
F4/80+	
MerTK+	CD11b+	
CX3CR1hi	
CD11c+/–	
CD64+	CD14+	
HLA-DR+	SIRPa+	
CD36+	
CD169–		
CD11c+/–			
58,69-71,81,184	
Skin	
Langerhans	Cells	
CD64–	F4/80+	
MerTK–	CD11c+	
CD11b+	EpCam+	
MHCII+	SIRPa+	
CD207+CD24+		
CD26-	
CD1a+	CD14+	
HLA-DR+	CD207+	
		
78,79,81,82	
Dermal		
CD64+	F4/80+	
MerTK+	EpCam–	
CD207–	MHCII+/–	
CD11c+/–	
CD64+	CD1a–	CD14+	
FXIIIa+	CD163+	
81,88,91	
Liver	 Kupffer	Cells	
CD64+	F4/80+	
MerTK+	MHCII+	
CD11bint	CD11clo	
Clec4F+	VSIG4+	
Tim4+	SIRPa+	
CX3CR1-	
CD64+		
CD163+	
CD68+	VSIG4+	
Tim4+	
	
	
23,81,93,95-100,176	
	
	
	
	
	
	
